Sulfogalactosylceramides in motor and psycho-cognitive adult metachromatic leukodystrophy: relations between clinical, biochemical analysis and molecular aspects

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 3, 2008, Pages 434-440

  Colsch, Benoit ^a,b   Afonso, Carlos ^a   Turpin, Jean Claude ^b   Portoukalian, Jacques ^c   Tabet, Jean Claude ^a   Baumann, Nicole ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Mass spectrometry; Metachromatic leukodystrophy; Schizophrenia; Sulfatides; Urine

Indexed keywords

CERAMIDE DERIVATIVE; CEREBROSIDE SULFATASE; FATTY ACID; SULFATIDE;

ADOLESCENT; ADULT; ARTICLE; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CLINICAL STUDY; COGNITION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ASSAY; FATTY ACID SYNTHESIS; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; MASS SPECTROMETRY; MENTAL TEST; METACHROMATIC LEUKODYSTROPHY; MOTOR SYSTEM; MUTATION; PRIORITY JOURNAL; PSYCHIATRY; PSYCHOLOGY; QUANTITATIVE ANALYSIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHROMATOGRAPHY, THIN LAYER; COGNITION DISORDERS; FEMALE; GALACTOSYLCERAMIDES; HUMANS; LEUKODYSTROPHY, METACHROMATIC; MALE; MASS SPECTROMETRY; SULFOGLYCOSPHINGOLIPIDS;

SPHINGOIDEA;

EID: 40849085451     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.10.004     Document Type: Article

References (40)

1. Baumann N., and Pham-Dinh D. Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol. Rev. 81 (2001) 871-927
2. Pernber Z., Molander-Melin M., Berthold C.H., Hansson E., and Fredman P. Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neuronand astrocytes of adult rat brain. J. Neurosci. Res. 69 (2002) 86-93
3. Ishizuka I. Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36 (1997) 245-319
4. Ishibashi T., Dupree J.L., Ikenaka K., Hirahara Y., Honke K., Peles E., Popko B., Suzuki K., Nishino H., and Baba H. A myelin galactolipid, sulfatide, is essential for maintenance of ion channels on myelinated axon but not essential for initial cluster formation. J. Neurosci. 22 (2002) 6507-6514
5. Honke K., Hirahara Y., Dupree J., Suzuki K., Popko B., Fukushima K., Fukushima J., Nagasawa T., Yoshida N., Wada Y., and Taniguchi N. Paranodal junction formation and spermatogenesis require sulfoglycolipids. Proc. Natl. Acad. Sci. U. S. A. 99 (2002) 4227-4232
6. Marcus J., Honigbaum S., Shroff S., Honke K., Rosenbluth J., and Dupree J.L. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia 53 (2006) 372-381
7. Von Figura K., Gieselmann V., and Jaeken J. Metachromatic leukodystrophy. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Childs B., Kinzler K.W., and Vogelstein B B. (Eds). Metabolic basis of inherited disease. 8th edition (2001), McGraw-Hill, New York 3695-3724
8. Rauschka H., Colsch B., Baumann N., Wevers R., Schmidtbauer M., Krammer M., Turpin J.C., Lefevre M., Olivier C., Tardieu S., Krivit W., Moser H., Moser A., Giselmann V., Zalc B., Cox T., Reuner U., Tylki-Szimanska A., Aboul-Enein F., Leguern E., Bernheimer H., and Berger J. Late onset metachromatic leukodystrophy: genotype strongly influences phenotype. Neurology 67 (2006) 859-863
9. Hyde T.M., Ziegler J.C., and Weinberger D.R. Psychiatric disturbances in metachromatic leukodystrophy. Arch. Neurol. 49 (1992) 401-406
10. Foong J., Maier M., Barker G.J., Brocklehurst S., Miller D.H., and Ron M.A. In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging. J. Neurol. Neurosurg. Psychiatry 68 (2000) 70-74
11. Stewart D.G., and Davis K.L. Possible contibutions of myelin and oligodendrocyte dysfunction to schizophrenia. Int. Rev. Neurobiol. 59 (2004) 381-424
12. Kubicki M., McCarley R.W., and Shenton M.E. Evidence for white matter abnormalities in schizophrenia. Curr. Opin. Psychiatry 18 (2005) 121-134
13. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12 (1975) 189-198
14. Grober E., Buschke H., Crystal H., Bang S., and Dresner R. Screening for dementia by memory testing. Neurology 38 (1988) 900-903
15. Dubois B., Slachevsky A., Litvan I., and Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 55 (2000) 1621-1626
16. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
17. Dubois G., Turpin J.C., and Baumann N. Utilisation de l'électrophorèse pour la détection de la Leucodystrophie Métachromatique à partir de leucocytes humains. C. R. Acad. Sci. Paris 278 (1974) 1401-1403
18. Wenger D.A., and Williams C. Screening for lysosomal disorders. In: Hommes F.A. (Ed). Techniques in Diagnostic Human Biochemical Genetics. A laboratory manual (1991), Wiley-Liss Inc. 587-617
19. Baumann N., Turpin J.C., Lefevre M., and Colsch B. Motor and psycho-cognitive clinical types in adult metachromatic leukodystrophy : genotype/phenotype relationships?. J. Physiol. (Paris) 96 (2002) 301-306
20. Rafi M.A., Coppola S., Liu S.L., Rao H.Z., and Wenger D.A. Disease-causing mutations in cis with the common arylsulfatase A pseudo-deficiency allele compound the difficulties in accurately identifying patients and carriers of metachromatic leukodystrophy. Molecular Genetics and Metabolism 79 (2003) 83-90
21. Korey S.R., Gomez C.J., Stein A., Gonatas J., Suzuki K., Terry R.D., and Weiss M. Studies in Tay Sachs disease. I. A. Methods. J. Neuropathol. Exp. Neurol. 22 (1963) 2-9
22. Neskovic N.M., Sarlieve L.L., Mandel P., and P. Biosynthesis of glycolipids in myelin deficient mutants: brain glycosyl transferases in jimpy and quaking mice. Brain Res. 42 (1972) 147-157
23. Dittmer J.C., and Lester R.L. A simple, specific spray for the detection of phospholipids on thin-layer chromatograms. J. Lipid Res. 15 (1964) 126-127
24. Fewster M.E., Burns B.J., and Mead J.F. Quantitative densitometric thin-layer chromatography of lipids using copper acetate reagent. J. Chromatogr. 43 (1969) 120-126
25. Anand J.K., Sadozai K.K., and Hakomori S. A simple method for the synthesis of ceramides and radiolabeled analogues. Lipids 9 (1996) 995-998
26. Sugiyama E., Hara A., and Uemura K. A quantitative analysis of serum sulfatide by matrix-assisted laser desorption ionization time-of-flight mass spectrometry with delayed ion extraction. Anal. Biochem. 274 (1999) 90-97
27. Naoi M., Lee Y.C., and Roseman S. Rapid and sensitive determination of sphingosine bases and sphingolipids with fluorescamine. Anal. Biochem. 58 (1974) 571-577
28. Arnott D. Basics of triple-stage quadrupole/ion trap mass spectrometry : precursor, product and neutral-loss scanning. Electrospray ionization and nanospray ionization. In: James P. (Ed). Proteome Research Mass Spectrometry (2001), Springer-Verlag, Germany 11-31
29. Hsu F.F., Bohrer J., and Turk J. Electrospray ionization tandem mass spectrometric analysis of sulfatide. Determination of fragmentation patterns and characterization of molecular species in brain and in pancreatic islets. Biochim. Biophys Acta 1392 (1998) 202-216
30. Filley C. The behavioral neurology of cerebral white matter. Neurology 50 (1998) 1535-1545
31. Weinberger D.R., and Lipska B.K. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophren. Res. 16 (1995) 87-110
32. Winterer G., Musso F., Beckmann C., Mattay V., Egan M.F., Jones D.W., Callicott J.H., Coppola R., and Weinberger D.R. Instability of prefrontal signal processing in schizophrenia. Am. J. Psychiatry 163 (2006) 1960-1968
33. Yakovlev P.I., and Lecours A.R. The myelinogenic cycles of regional maturation of the brain. In: Minkovski A. (Ed). Regional development of the brain in early life (1966), Blackwell Oxford, UK 3-70
34. Beckman M. Crime, culpability and the adolescent brain. Science 305 (2004) 596-599
35. Lugowska A., Tylki-Szymanska A., Berger J., and Molzer B. Elevated sulfatide excretion in compound heterozygotes of metachromatic leukodystrophy and ASA-pseudodeficiency allele. Clinical Biochemistry 30 (1997) 325-331
36. Whitfield P.D., Sharp P.C., Johnson D.W., Nelson P., and Meikle P.J. Characterization of urinary sulfatides in metachromatic leukodystrophy using electrospray-tandem mass spectrometry. Molecular Genetics and Metabolism 73 (2001) 30-37
37. Issac G., Pernber Z., Gieselmann V., Hansson E., Bergquist J., and Mansson J.E. Sulfatide with short chain fatty acids dominates in astrocytes and neurons. FEBS Journal 273 (2006) 17882-17886
38. Waheed A., and Van Etten R.L. Chemical characterization and substrate specificity of rabbit liver aryl sulfatase A. Biochim. Biophys. Acta 614 (1980) 92-101
39. Strobel G., Werle E., and Weicker H. Isomer specific kinetics of dopamine beta-hydroxylase and arylsulfatase towards catecholamine sulfates. Biochem. Int. 20 (1990) 343-351
40. Fluharty A.L., Stevens R.L., Goldstein E.B., and Kihara H. The activity of arylsulfatase A and B on tyrosine o-sulfates. Biochim. Biophys. Acta 566 (1979) 321-326